Skip to content

Vivani Medical VANI Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Eli Lilly logo
Eli LillyLLY
Prime Medicine logo
Prime MedicinePRME

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's accrued manufacturing costs?
Vivani Medical (VANI) reported accrued manufacturing costs of $349K in Q1 2026.
How has Vivani Medical's accrued manufacturing costs changed year-over-year?
Vivani Medical's accrued manufacturing costs decreased by 0.3% year-over-year, from $350K to $349K.
What is the long-term trend for Vivani Medical's accrued manufacturing costs?
Over 5 years (2020 to 2025), Vivani Medical's accrued manufacturing costs has grown at a 16.1% compound annual growth rate (CAGR), from $173K to $365K.